Interim report January – September 2024 for CombiGene AB (publ)
July – September 2024• Net sales: TSEK 0 (992).• Other operating revenues: TSEK 793 (173).• Profit
July – September 2024• Net sales: TSEK 0 (992).• Other operating revenues: TSEK 793 (173).• Profit
April – June 2024Net sales: TSEK 0 (1,788).Other operating revenues: TSEK 416 (1,413).Profit from financial items:
January – March 2024Net sales: TSEK 326 (2,168).Other operating revenues: TSEK 1,042 (0).Profit from financial items:
CombiGene announces that the annual report now is available on the Company´s homepage, www.combigene.com, and as
October – December 2023• Net sales: TSEK 596 (5,346).• Other operating revenues: TSEK 875 (579).• Profit
July – September 2023• Net sales: TSEK 992 (5,213).• Other operating revenues: TSEK 173 (8,285).• Profit
April – June 2023• Net sales: TSEK 1,788 (4,738).• Other operating revenues: TSEK 1,413 (9,800).• Profit
January – March 2023• Net sales: TSEK 2,168 (11,403).• Other operating revenues: TSEK 0 (2,801).• Profit
CombiGene announces that the annual report now is available on the Company´s homepage, www.combigene.com, and as
October – December 2022• Net sales: TSEK 5,346 (84,042).• Other operating revenues: TSEK 674 (1,098).• Profit